Vitamin D and Dysfunctional Adipose Tissue in Obesity

Angiology

Volumn 66, Issue 7, 2015, Pages 613-618

  Stokić, Edita ^a   Kupusinac, Aleksandar ^b   Tomic Naglic, Dragana ^a   Smiljenic, Dragana ^a   Kovacev Zavisic, Branka ^a   Srdic Galic, Biljana ^a   Soskic, Sanja ^c   Isenovic, Esma R ^c  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

adipocytokine; dysfunctional adipose tissue; obesity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; LEPTIN; RESISTIN; VITAMIN D; BIOLOGICAL MARKER;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; FAT MASS; FEMALE; HUMAN; HUMAN TISSUE; MALE; OBESITY; PROTEIN BLOOD LEVEL; TRUNK FAT MASS; VITAMIN BLOOD LEVEL; WAIST CIRCUMFERENCE; ANTHROPOMETRY; BLOOD; CLASSIFICATION; COMPLICATION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; PATHOPHYSIOLOGY; VITAMIN D DEFICIENCY;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LEPTIN; MALE; OBESITY; RESISTIN; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84937917766     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714543512     Document Type: Article

References (42)

1. Must A, Strauss RS,. Risks and consequences of childhood and adolescent obesity. Int J Obes Relat Metab Disord. 1999; 23 (suppl 2): S2-S11.
2. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National institutes of health. Obes Res. 1998; 6 (suppl 2): 51S-209S.
3. WHO. Global health risk: mortality and burden of diseases attributable to selected major risks. 2009. http://www.who.int/healthinfo/global-burden-disease/GlobalHealthRisk-report-full.pdf. (Accessed on October 28, 2009)
4. Tomić-Naglić D SE, Srdić B, Radovanov T,. Masno tkivo kao endokrina Zlezda. Medicina Danas. 2008; 7 (4-6): 142-147.
5. Murdolo G, Smith U,. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis. Nutr Metab Cardiovasc Dis. 2006; 16 (suppl 1): S35-S38.
6. Kershaw EE, Flier JS,. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004; 89 (6): 2548-2556.
7. Aquilante CL, Kosmiski LA, Knutsen SD, Zineh I,. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults. Metabolism. 2008; 57 (4): 494-501.
8. Ohmori R, Momiyama Y, Kato R,. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol. 2005; 46 (2): 379-380.
9. Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP,. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview [published online April 25, 2013]. Curr Vasc Pharmacol. 2013.
10. Koerner A, Kratzsch J, Kiess W,. Adipocytokines: leptin-the classical, resistin-the controversial, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab. 2005; 19 (4): 525-546.
11. Misra A, Vikram NK,. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition. 2003; 19 (5): 457-466.
12. Stokić E, Srdić Galić B, Tomić-Naglić D, Isenović E,. Sagittal abdominal diameter (SAD) in identification obese patients of higher cardiovascular risk. Cardiology. 2013; 126: 169.
13. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B,. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006; 84 (1): 18-28.
14. Vanlint S,. Vitamin D and obesity. Nutrients. 2013; 5 (3): 949-956.
15. Chiu KC, Chu A, Go VL, Saad MF,. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004; 79 (5): 820-825.
16. Scragg R, Sowers M, Bell C,. Third National H, nutrition examination S. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004; 27 (12): 2813-2818.
17. Anderson JL, May HT, Horne BD,. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010; 106 (7): 963-968.
18. Earthman CP, Beckman LM, Masodkar K, Sibley SD,. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond). 2012; 36 (3): 387-396.
19. Stokic E, Kupusinac A, Tomic-Naglic D,. Obesity and vitamin D deficiency: trends to promote a more proatherogenic cardiometabolic risk profile. Angiology. 2015; 66 (3): 237-243.
20. Need AG, OLoughlin PD, Horowitz M, Nordin BE,. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf). 2005; 62 (6): 738-741.
21. Vilarrasa N, Vendrell J, Maravall J,. Is plasma 25(OH)D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine. 2010; 38 (2): 235-242.
22. Kempt Am SM, Li C, Kaur H, Huang Tt,. Leptin is a maker of body fat and hyperinsulinemia in college students. J Am Coll Nutr. 2006; 55 (3): 175-180.
23. Kim M, Na W, Sohn C,. Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans. J Clin Biochem Nutr. 2013; 52 (2): 167-171.
24. Liu E, Meigs JB, Pittas AG,. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009; 139 (2): 329-334.
25. Al-Daghri NM, Al-Attas OS, Alokail MS,. Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with type 2 diabetes mellitus: a body mass index-independent role of adiponectin? J Endocrinol Invest. 2013; 36 (1): 1-6.
26. Lips P,. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol. 2010; 121 (1-2): 297-300.
27. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH,. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988; 43 (4): 199-201.
28. Hyldstrup L, Andersen T, Mcnair P, Breum L, Transbol I,. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol (Copenh). 1993; 129 (5): 393-398.
29. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF,. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72 (3): 690-693.
30. Kong J, Chen Y, Zhu G, Zhao Q, Li YC,. 1,25-Dihydroxyvitamin D3 upregulates leptin expression in mouse adipose tissue. J Endocrinol. 2013; 216 (2): 265-271.
31. Indulekha K, Anjana RM, Surendar J, Mohan V,. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem. 2011; 44 (4): 281-287.
32. Ding C, Parameswaran V, Cicuttini F,. Association between leptin, body composition, sex and knee cartilage morphology in older adults: the Tasmanian older adult cohort (TASOAC) study. Ann Rheum Dis. 2008; 67 (9): 1254-1256.
33. Maetani M, Maskarinec G, Franke AA, Cooney RV,. Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr Cancer. 2009; 61 (2): 225-231.
34. Abate N, Sallam HS, Rizzo M,. Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome [published online December 5, 2013]. Curr Pharm Des. 2013.
35. Roth CL, Elfers C, Kratz M, Hoofnagle AN,. Vitamin D deficiency in obese children and its relationship to insulin resistance and adipokines. J Obes. 2011; 2011: 495101.
36. Ohashi K, Ouchi N, Matsuzawa Y,. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 2012; 94 (10): 2137-2142.
37. Scherer PE,. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006; 55 (6): 1537-1545.
38. Nimitphong H, Chanprasertyothin S, Jongjaroenprasert W, Ongphiphadhanakul B,. The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine. 2009; 36 (2): 205-210.
39. Roth CL, Kratz M, Ralston MM, Reinehr T,. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism. 2011; 60 (4): 445-452.
40. Vaidya A, Williams JS, Forman JP,. The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring). 2012; 20 (1): 186-191.
41. Kupusinac A SE, Srdić Galić B,. Determination of WHtR limit for predicting hyperglycemia in obese persons by using artificial neural networks. TEM J. 2012; 1 (4): 270-272.
42. Stokić E, Kupusinac A, Doroslovaɥki R,. Estimating SAD low-limits for the adverse metabolic profile by using artificial neural networks. TEM J. 2013 (2): 115-119.